Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Altimmune (ALT) Depreciation Expense (2016 - 2017)

Altimmune (ALT) has disclosed Depreciation Expense for 6 consecutive years, with $33007.0 as the latest value for Q1 2017.

  • Quarterly Depreciation Expense fell 12.45% to $33007.0 in Q1 2017 from the year-ago period, while the trailing twelve-month figure was $138743.0 through Mar 2017, down 2.43% year-over-year, with the annual reading at $143437.0 for FY2016, 1.29% up from the prior year.
  • Depreciation Expense for Q1 2017 was $33007.0 at Altimmune, roughly flat from $33066.0 in the prior quarter.
  • The five-year high for Depreciation Expense was $52602.0 in Q1 2013, with the low at $32235.0 in Q3 2016.
  • Average Depreciation Expense over 5 years is $38264.3, with a median of $37106.0 recorded in 2015.
  • The sharpest move saw Depreciation Expense crashed 38.45% in 2013, then increased 10.22% in 2016.
  • Over 5 years, Depreciation Expense stood at $43438.0 in 2013, then fell by 15.54% to $36686.0 in 2014, then dropped by 10.58% to $32806.0 in 2015, then rose by 0.79% to $33066.0 in 2016, then decreased by 0.18% to $33007.0 in 2017.
  • According to Business Quant data, Depreciation Expense over the past three periods came in at $33007.0, $33066.0, and $32235.0 for Q1 2017, Q4 2016, and Q3 2016 respectively.